Hong Jiang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Acute Respiratory Distress Syndrome

Inflammatory Response

Top Venues

The Journal of experimental medicine

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Mika P Cadiz, Katelin A Gibson, Kennedi T Todd, David G Nascari, Nashali Massa, Meredith T Lilley, Kimberly C Olney, Md Mamun Al-Amin, Hong Jiang, David M Holtzman, John D Fryer
Aducanumab anti-amyloid immunotherapy induces sustained microglial and immune alterations. The Journal of experimental medicine 221 (2) (2024)
Mika P Cadiz, Katelin A Gibson, Kennedi T Todd, David G Nascari, Nashali Massa, Meredith T Lilley, Kimberly C Olney, Md Mamun Al-Amin, Hong Jiang, David M Holtzman, John D Fryer
Aducanumab anti-amyloid immunotherapy induces sustained microglial and immune alterations. The Journal of experimental medicine 221 (2) (2024)
Mika P Cadiz, Katelin A Gibson, Kennedi T Todd, David G Nascari, Nashali Massa, Meredith T Lilley, Kimberly C Olney, Md Mamun Al-Amin, Hong Jiang, David M Holtzman, John D Fryer
Aducanumab anti-amyloid immunotherapy induces sustained microglial and immune alterations. The Journal of experimental medicine 221 (2) (2024)
Mika P Cadiz, Katelin A Gibson, Kennedi T Todd, David G Nascari, Nashali Massa, Meredith T Lilley, Kimberly C Olney, Md Mamun Al-Amin, Hong Jiang, David M Holtzman, John D Fryer
Aducanumab anti-amyloid immunotherapy induces sustained microglial and immune alterations. The Journal of experimental medicine 221 (2) (2024)
Mika P Cadiz, Katelin A Gibson, Kennedi T Todd, David G Nascari, Nashali Massa, Meredith T Lilley, Kimberly C Olney, Md Mamun Al-Amin, Hong Jiang, David M Holtzman, John D Fryer
Aducanumab anti-amyloid immunotherapy induces sustained microglial and immune alterations. The Journal of experimental medicine 221 (2) (2024)
Mika P Cadiz, Katelin A Gibson, Kennedi T Todd, David G Nascari, Nashali Massa, Meredith T Lilley, Kimberly C Olney, Md Mamun Al-Amin, Hong Jiang, David M Holtzman, John D Fryer
Aducanumab anti-amyloid immunotherapy induces sustained microglial and immune alterations. The Journal of experimental medicine 221 (2) (2024)
Mika P Cadiz, Katelin A Gibson, Kennedi T Todd, David G Nascari, Nashali Massa, Meredith T Lilley, Kimberly C Olney, Md Mamun Al-Amin, Hong Jiang, David M Holtzman, John D Fryer
Aducanumab anti-amyloid immunotherapy induces sustained microglial and immune alterations. The Journal of experimental medicine 221 (2) (2024)
Monica Xiong, Hong Jiang, Javier Remolina Serrano, Ernesto R Gonzales, Chao Wang, Maud Gratuze, Rosa Hoyle, Nga Bien-Ly, Adam P Silverman, Patrick M Sullivan, Ryan J Watts, Jason D Ulrich, Gregory J Zipfel, David M Holtzman
APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function. Science translational medicine 13 (581) (2021)